XML 82 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-based Compensation Expense
12 Months Ended
Dec. 29, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based Compensation Expense
Share-based Compensation Expense

Total share-based compensation expense for all stock awards consists of the following (in thousands):

 
Years Ended
 
December 29,
2013
 
December 30,
2012
 
January 1,
2012
Cost of product revenue
$
6,223

 
$
7,575

 
$
6,951

Cost of service and other revenue
777

 
461

 
695

Research and development
37,439

 
30,879

 
32,105

Selling, general and administrative
61,387

 
55,409

 
52,341

Share-based compensation expense before taxes
105,826

 
94,324

 
92,092

Related income tax benefits
(32,819
)
 
(30,759
)
 
(32,168
)
Share-based compensation expense, net of taxes
$
73,007

 
$
63,565

 
$
59,924



The assumptions used for the specified reporting periods and the resulting estimates of weighted-average fair value per share of options granted and for stock purchased under the ESPP during those periods are as follows:

 
Years Ended
 
December 29,
2013
 
December 30,
2012
 
January 1,
2012
Stock options granted:
 
 
 
 
 
Risk-free interest rate
0.14 - 1.86%

 
0.56 - 0.93%

 
0.85 - 2.23%

Expected volatility
30 - 44%

 
41 - 48%

 
41 - 53%

Expected term
0.8 - 9.4 years

 
4.0 - 6.6 years

 
4.7 - 5.5 years

Expected dividends

 

 

Weighted average fair value per share
$
40.66

 
$
15.47

 
$
27.47

 
 
 
 
 
 
Stock purchased under the ESPP:
 
 
 
 
 
Risk-free interest rate
0.08 - 0.15%

 
0.09 - 0.17%

 
0.16 - 0.30%

Expected volatility
31 - 32%

 
33 - 64%

 
43 - 48%

Expected term
0.5 - 1.0 year

 
0.5 - 1.0 year

 
0.5 - 1.0 year

Expected dividends

 

 

Weighted average fair value per share
$
19.30

 
$
16.45

 
$
20.08



As of December 29, 2013, approximately $216.9 million of total unrecognized compensation cost related to stock options, restricted stock, and ESPP shares issued to date is expected to be recognized over a weighted-average period of approximately 2.2 years.